Clinical Trial Update: Inhaled Isoflurane for Sedation of Invasively Ventilated Patients With Cardiogenic Shock on Extracorporeal Membrane Oxygenation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating inhaled isoflurane for sedation of invasively ventilated patients with cardiogenic shock on ECMO; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• Isoflurane (inhaled) (isoflurane)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cardiogenic Shock, ECMO | Phase 3 | Status: NOT_YET_RECRUITING